ENDOSCOPIC, HISTOLOGIC, AND COMBINED OUTCOMES WITH REINITIATION OF OZANIMOD AFTER TEMPORARY DISCONTINUATION: 2-YEAR INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Regueiro, Miguel D.
Dignass, Axel
Colombel, Jean Frederic
Jain, Anjali
Canavan, James B.
Wu, Hsiuanlin
Lawlor, Garrett
Osterman, Mark T.
Rubin, David T.
Vermeire, Severine
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1742
引用
收藏
页码：S1105 / S1105
页数：1
相关论文
共 50 条
  • [1] Endoscopic, histologic, and combined outcomes with reinitiation of ozanimod after temporary discontinuation: 2-year interim analysis of the True North open-label extension study
    Vermeire, S.
    Dignass, A.
    Colombel, J. F.
    Jain, A.
    Canavan, J. B.
    Wu, H.
    Lawlor, G.
    Osterman, M. T.
    Rubin, D. T.
    Regueiro, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I103 - I104
  • [2] Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
    Vermeire, S.
    Colombel, J. F.
    Rubin, D. T.
    Ghosh, S.
    Jain, A.
    Lawlor, G.
    Osterman, M. T.
    Wu, H.
    Canavan, J. B.
    Chiorean, M. V.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 844 - 845
  • [3] ACHIEVEMENT AND MAINTENANCE OF ENDOSCOPIC, HISTOLOGIC, AND COMBINED OUTCOMES AFTER EXTENDED INDUCTION IN WEEK 10 NONRESPONDERS OF OZANIMOD: 2-YEAR INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Chiorean, Michael V.
    Colombel, Jean Frederic
    Rubin, David T.
    Ghosh, Subrata
    Jain, Anjali
    Lawlor, Garrett
    Osterman, Mark T.
    Wu, Hsiuanlin
    Canavan, James B.
    Vermeire, Severine
    GASTROENTEROLOGY, 2023, 164 (06) : S1106 - S1107
  • [4] Efficacy and Safety of 2 Years of Continuous Ozanimod Treatment: Interim Analysis of the True North Open-Label Extension Study
    Abreu, Maria T.
    Dulai, Parambir
    Dignass, Axel
    Savarino, Edoardo
    Hudesman, David
    Afzali, Anita
    Jairath, Vipul
    Osterman, Mark
    Akukwe, Lucy
    Liu, W. Jerry
    Memaj, Arteid
    Petersen, AnnKatrin
    Jain, Anjali
    Canavan, James B.
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S537 - S537
  • [5] Delayed Response to Ozanimod in Patients with Moderate vs Severe Endoscopic Disease: 4-Year Interim Analysis of the True North Open-Label Extension Study
    Wolf, Douglas C.
    Cross, Raymond K.
    Ritter, Timothy E.
    Stallmach, Andreas
    Hindryckx, Pieter
    Chang, Shannon
    Tharmarajah, Soba
    Wu, Hsiuanlin
    Osterman, Mark T.
    Jain, Anjali
    Irving, Peter M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1035 - S1035
  • [6] Efficacy and safety of 3 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study
    Danese, S.
    Abreu, M. T.
    Wolf, D. C.
    Canavan, J. B.
    Jain, A.
    Wu, H.
    Petersen, A.
    Charles, L.
    Panaccione, R.
    Afzali, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I101 - I102
  • [7] Efficacy and safety of 3 years of continuous ozanimod treatment: An interim analysis of the True North open-label extension study
    Danese, S.
    Sparrow, M.
    Abreu, M. T.
    Wolf, D. C.
    Canavan, J. B.
    Jain, A.
    Wu, H.
    Petersen, A.
    Charles, L.
    Panaccione, R.
    Afzali, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 121 - 122
  • [8] Efficacy and safety of 4 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study
    D'Haens, G.
    Sands, B. E.
    Ferrante, M.
    Matsuoka, K.
    Lindsay, J. O.
    Blumenstein, I.
    Mehra, D.
    Charles, L.
    Cetin, V.
    Petersen, A.
    Wu, H.
    Wang, D.
    Jain, A.
    Hanauer, S. B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1814 - I1815
  • [9] EXTENDED INDUCTION IN THE TRUE NORTH OPEN-LABEL EXTENSION STUDY: CLINICAL OUTCOMES OF ∼2 YEARS OF OZANIMOD TREATMENT
    Rubin, David T.
    Colombel, Jean Frederic
    Chiorean, Michael V.
    Ghosh, Subrata
    Jain, Anjali
    Lawlor, Garrett
    Osterman, Mark T.
    Wu, Hsiuanlin
    Canavan, James B.
    Vermeire, Severine
    GASTROENTEROLOGY, 2023, 164 (06) : S1102 - S1102
  • [10] Extended induction in the True North open-label extension study: clinical outcomes of ∼2 years of ozanimod treatment
    Vermeire, S.
    Colombel, J. F.
    Chiorean, M. V.
    Ghosh, S.
    Jain, A.
    Lawlor, G.
    Osterman, M. T.
    Wu, H.
    Canavan, J. B.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 903 - 904
12345